Virpax Pharmaceuticals (VPRX) IPO Opens 20% Lower

Today's IPO for Virpax Pharmaceuticals Inc. (NASDAQ: VRPX) opened for trading at $8 after priding 1,800,000 shares of its common stock at a public offering price of $10.00 per share.

ThinkEquity, a division of Fordham Financial Management, Inc., is acting as sole book-running manager for the offering.

Virpax is a preclinical stage biopharmaceutical company focused on becoming a global leader in pain management by developing and delivering innovative non-opioid and non-addictive pharmaceutical products using new drug delivery systems and technology. Virpax is developing branded pharmaceutical product candidates for pain management by using advanced technology in an effort to enhance patients' quality of life. For more information, please visit www.virpaxpharma.com.

You May Also Be Interested In

• Karman Line Acquisition closes $200M IPO on Nasdaq
• NorthStrive Acquisition prices $100M IPO on Nasdaq
• Singularity Future Technology closes $1.8M registered direct offering